Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Planta Medica

• Publication date

  2010-01-27

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1055/s-0029-1240815PMID 20108175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of P-Glycoprotein-Mediated Paclitaxel Resistance by Reversibly Linked Quinine Homodimers

  2009cited by this paper
• Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of B-cell lymphoma 2 phosphorylation suppression.

  2009cited by this paper
• P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration.

  2009cited by this paper
• Insulin therapy restores impaired function and expression of P-glycoprotein in blood-brain barrier of experimental diabetes.

  2008cited by this paper
• Effects of monoglycerides on P-glycoprotein: modulation of the activity and expression in Caco-2 cell monolayers.

  2008cited by this paper
• Evaluation of carbamazepine pharmacokinetic profiles in mice with kainic acid-induced acute seizures.

  2008cited by this paper
• Attenuated function and expression of P-glycoprotein at blood-brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice.

  2007cited by this paper
• Down-Regulation of Intestinal Drug Transporters in Chronic Renal Failure in Rats

  2007cited by this paper
• Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1.

  2007cited by this paper
• Toxicity of diazinon and its metabolites increases in diabetic rats.

  2007cited by this paper
• Impact of inflammation on the duodenal mRNA expression of CYP3A and P‐glycoprotein in children with Crohn's disease

  2006cited by this paper
• Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.

  2006cited by this paper
• Expression and function of efflux drug transporters in the intestine.

  2006cited by this paper
• Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats.

  2006cited by this paper
• Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes.

  2006cited by this paper
• Bioavailability of genistein and its glycoside genistin as measured in the portal vein of freely moving unanesthetized rats.

  2006cited by this paper
• Protective role of Coptidis Rhizoma alkaloids against peroxynitrite‐induced damage to renal tubular epithelial cells

  2005cited by this paper
• Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.

  2005cited by this paper
• Effect of CYP3A1(23) Induction on Clarithromycin Pharmacokinetics in Rats with Diabetes Mellitus

  2005cited by this paper
• Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma.

  2005cited by this paper
• Effects of first- and second-generation histamine-H1-receptor antagonists on the pentobarbital-induced loss of the righting reflex in streptozotocin-induced diabetic mice.

  2005cited by this paper
• Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

  2004cited by this paper
• P-Glycoprotein Increases from Proximal to Distal Regions of Human Small Intestine

  2003cited by this paper
• Differential Effect of Acute Hepatic Failure on in Vivo and in Vitro P-Glycoprotein Functions in the Intestine

  2003cited by this paper
• A Kinetic Evaluation of the Absorption, Efflux, and Metabolism of Verapamil in the Autoperfused Rat Jejunum

  2003cited by this paper
• The involvement of P-glycoprotein in berberine absorption.

  2002cited by this paper
• Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by a Coptidis Rhizoma Extract and Protoberberine Alkaloids

  2002cited by this paper
• Effect of Endotoxin on P-Glycoprotein-Mediated Biliary and Renal Excretion of Rhodamine-123 in Rats

  2001cited by this paper
• Effect of cyclosporine, a P-glycoprotein inhibitor, on the pharmacokinetics of cefepime in rat blood and brain: a microdialysis study.

  2001cited by this paper
• The effect of berberine chloride on experimental colitis in rats in vivo and in vitro.

  2000cited by this paper
• Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6.

  2000cited by this paper
• Effect of bitter melon (Momordica charantia) fruit juice on the hepatic cytochrome P450-dependent monooxygenases and glutathione S-transferases in streptozotocin-induced diabetic rats.

  1996cited by this paper
• Inhibitory effects of berberine-type alkaloids on elastase.

  1993cited by this paper
• On the mechanism of vasodilating action of berberine: possible role of inositol lipid signaling system.

  1992cited by this paper

• Anticancer and Anti‐Inflammatory Potential of Coptisine as a Planar Quaternary Benzo[C]Phenanthridine Alkaloid With G‐Quadruplex DNA Telomeric Induction Activity

  2025cites this paper
• Botanical Sources, Pharmacokinetics, and Therapeutic Efficacy of Palmatine and Its Derivatives in the Management of Cancer: A Comprehensive Mechanistic Analysis

  2024cites this paper
• Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice

  2022cites this paper
• Pharmacokinetics of Five Alkaloids and their Metabolites in Normal and Diabetic Rats after Oral Administration of Rhizoma coptidis

  2021influential citation
• Influence of Diet-Induced Obesity on the Bioavailability and Metabolism of Raspberry Ketone (4-(4-Hydroxyphenyl)-2-Butanone) in Mice.

  2020cites this paper
• Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance

  2020cites this paper
• Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine

  2020cites this paper
• Palmatine: A review of pharmacological properties and pharmacokinetics

  2020cites this paper
• Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine

  2020cites this paper
• Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters

  2019cites this paper
• Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology

  2019cites this paper
• Short‐chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P‐glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats

  2019cites this paper
• ABC Family Transporters.

  2019cites this paper
• Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review

  2019cites this paper
• Co‐administration of nuciferine reduces the concentration of metformin in liver via differential inhibition of hepatic drug transporter OCT1 and MATE1

  2018cites this paper
• Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity

  2018cites this paper
• Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?

  2018cites this paper
• Network pharmacology‐based prediction of the active ingredients, potential targets, and signaling pathways in compound Lian‐Ge granules for treatment of diabetes

  2018cites this paper
• Comparative Pharmacokinetic Study of Mangiferin in Normal and Alloxan-Induced Diabetic Rats after Oral and Intravenous Administration by UPLC-MS/MS

  2018cites this paper
• MAPK/P53-mediated FASN expression in bone tumors

  2017cites this paper
• Comparative Metabolism Study of Five Protoberberine Alkaloids in Liver Microsomes from Rat, Rhesus Monkey, and Human

  2017cites this paper
• The oral bioavailability, excretion and cytochrome P450 inhibition properties of epiberberine: an in vivo and in vitro evaluation

  2017cites this paper
• Efficacy and safety of Sancai powder in patients with type 2 diabetes mellitus: a randomized controlled trial.

  2016cites this paper
• Epiberberine reduces serum cholesterol in diet-induced dyslipidemia Syrian golden hamsters via network pathways involving cholesterol metabolism.

  2016cites this paper
• Altered Transport and Metabolism of Phenolic Compounds in Obesity and Diabetes: Implications for Functional Food Development and Assessment.

  2016cites this paper
• ASBT: apical sodium-dependent bile salt transporter CYP7A1: cholesterol 7α-hydroxylase DM: diabetes mellitus FGF: fibroblast growth factor HDL: high-density lipoprotein HFHC: high fat and high cholesterol HMGCR: 3-hydroxy-3-methyl glutaryl coenzyme A reductase LDL: low-density lipoprotein LDLR: low-

  2016cites this paper
• Efficacy and safety of Sancai powder in patients with type 2 diabetes mellitus: a randomized controlled trial.

  2016cites this paper
• Hypolipidemic Effects of Alkaloids from Rhizoma Coptidis in Diet-Induced Hyperlipidemic Hamsters

  2016cites this paper
• Interaction of six protoberberine alkaloids with human organic cation transporters 1, 2 and 3

  2016influential citation
• The Alterations in the Expression and Function of P-Glycoprotein in Vitamin A-Deficient Rats as well as the Effect of Drug Disposition in Vivo

  2015cites this paper
• Combined contribution of increased intestinal permeability and inhibited deglycosylation of ginsenoside Rb1 in intestinal tract to the enhancement of ginsenoside Rb1 exposure in diabetic rats following oral administration

  2015cites this paper
• DMD064881 1702..1710

  2015cites this paper
• Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration

  2015cites this paper
• Paroxetine decreased plasma exposure of glyburide partly via inhibiting intestinal absorption in rats.

  2015cites this paper
• Effect of Rhizoma coptidis (Huang Lian) on Treating Diabetes Mellitus

  2015cites this paper
• Pharmacokinetics difference of multiple active constituents from decoction and maceration of Fuzi Xiexin Tang after oral administration in rat by UPLC-MS/MS.

  2014cites this paper
• Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications.

  2014cites this paper
• Pharmacochemistry and integrated pharmacokinetics of six alkaloids after oral administration of Huang-Lian-Jie-Du-Tang decoction

  2014cites this paper
• Pharmacokinetic properties, potential herb–drug interactions and acute toxicity of oral Rhizoma coptidis alkaloids

  2013cites this paper
• Involvement of rat organic cation transporter 2 in the renal uptake of jatrorrhizine.

  2013cites this paper
• Inhibition of ATP-Binding Cassette Transporters by Chinese Herbs and Phytochemicals

  2013cites this paper
• Differences in Pharmacokinetics and Anti-inflammatory Effects between Decoction and Maceration of Sanhuang Xiexin Tang in Rats and Mice

  2013cites this paper
• Dissolution and Pharmacokinetic Properties of Alkaloids and Flavonoids in a Xiexin Multiple-unit Drug Delivery System

  2013cites this paper
• Involvement of ubiquitination in the decrease of intestinal P-glycoprotein in a streptozotocin-induced diabetic mouse model.

  2012cites this paper
• Combined Contributions of Impaired Hepatic CYP2C11 and Intestinal Bcrp Activities and Expressions to Increased Exposure of Oral Glibenclamide in Streptozotocin-induced Diabetic Rats

  2012influential citation
• Increased Systemic Exposure to Rhizoma Coptidis Alkaloids in Lipopolysaccharide-Pretreated Rats Attributable to Enhanced Intestinal Absorption

  2012cites this paper
• Metabolism and Pharmacokinetics of Mangiferin in Conventional Rats, Pseudo-Germ-Free Rats, and Streptozotocin-Induced Diabetic Rats

  2012cites this paper
• 糖尿病および一過性腸管虚血病態モデルにおける腸管P-glycoproteinの発現・機能変動と薬物動態変化

  2012cites this paper
• Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response

  2012cites this paper
• Combined Contributions of Impaired Hepatic CYP2C11 and Intestinal Breast Cancer Resistance Protein Activities and Expression to Increased Oral Glibenclamide Exposure in Rats with Streptozotocin-Induced Diabetes Mellitus

  2012cites this paper
• P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs.

  2012cites this paper
• Tissue-specific alterations in expression and function of P-glycoprotein in streptozotocin-induced diabetic rats

  2011cites this paper
• In vitro and In vivo Relevance of the P-glycoprotein Probe Substrates in Drug Discovery and Development: Focus on Rhodamine 123, Digoxin and Talinolol

  2011cites this paper
• Opposite Effect of Diabetes Mellitus Induced by Streptozotocin on Oral and Intravenous Pharmacokinetics of Verapamil in Rats

  2011cites this paper
• The oral bioavailability, excretion and cytochrome P450 inhibition properties of epiberberine: an in vivo and in vitro evaluation

  year unknowncites this paper
• CLINICAL STUDY Efficacy and safety of Sancai powder in patients with type 2 diabetes mellitus: a randomized controlled trial

  year unknowncites this paper